College of Science students Adam Chvilicek and Delaney Weiland spent the summer volunteering with the Boston Health Care for the Homeless Program as they prepare for future careers in health care.
Biological sciences major Eunice Agyapong has spent the past two summers conducting research in a Kumasi hospital on doctor-patient relations.
The new program featured 19 students from seven campuses — Saint Mary’s College, Indiana University South Bend, Indiana University Bloomington, Goshen College and Ball State University, in addition to Notre Dame and IUSM-SB.
The new global health specialization, grounded in the social sciences, will prepare students for careers that address global health from a policy perspective.
Siyuan Zhang, the Dee Associate Professor of Biological Sciences who is also affiliated with the Harper Cancer Research Institute, landed a nearly $1.1 million Breast Cancer Research Program Breakthrough Award through the Department of Defense in August.
What role can Notre Dame play in the revolution building around rare disease research? A collaborative team of stakeholders discussed different options during a working session in October.
Researchers at the University of Notre Dame studying tumors in prostate cancer models found that nitration of an amino acid can inhibit T-cell activation, thwarting the T-cell’s ability to kill cancer cells.
Xin Lu, the John M. and Mary Jo Boler Assistant Professor of biology, was awarded a 2018 Susan G. Komen research grant to identify potential new therapies for treating metastatic breast cancer.
From Saturday, October 28 through Thursday, November 1, members of the University of Notre Dame research community will travel to New Orleans, LA for the annual American Society of Tropical Medicine and Hygiene (ASTMH) meeting. Of the over 40 Notre Dame faculty, researchers, and students in attendance, many will be presenting their research through lectures, presentations, and posters.
Guido Camargo España, postdoctoral research associate of biological sciences, has received a Postdoctoral Training Award inTranslational Research from the Indiana Clinical and Translational Sciences Institute (CTSI).
Perlara, a rare diseases drug discovery company based in the San Francisco Bay area, recently announced a collaboration called PerlQuest with the University of Notre Dame’s Warren Family Research Center for Drug Discovery and Development.
Several undergraduate students from the University of Notre Dame's College of Science spent their summers on campus conducting research on topics including medicine, ecology, physics and mathematics. Their enthusiasm and dedication toward their projects embodied the spirit of using scholarship and creative endeavor to advance scientific understanding of the world.
Not only do undergraduate science students at Notre Dame take part in the latest research during the academic year, but they also have the chance to expand their horizons during the summer by taking part in research elsewhere in the country—and the world.
Predicting how mutations in proteins alter their ability to function is critical to understanding what drives health and disease in humans. A new study in Structure, Cell Press by scientists at the University of Notre Dame and their colleagues demonstrates how a minor mutation can have far-reaching effects on a protein, playing a role in the onset of different diseases.
The body’s immune system is a valiant weapon against disease, and harnessing its power through a technique called immunotherapy is at the forefront of current research to treat cancer and other diseases.That’s why an unexpected finding by University of Notre Dame researchers and their collaborators, related to the way two distinctively different peptide antigens react with one T-cell receptor (TCR), tosses a new wrench into the process of building better molecules to develop immunotherapies.
